Reference
Matta A, et al. Ineffective subtilisin/kexin type 9 (Pcsk9) inhibitors monotherapy in dyslipidemia with low-density lipoprotein cholesterol (ldl-c) receptor abnormalities: A report of 2 cases. American Journal of Case Reports 21: 1-4, Jan 2020. Available from: URL: http://doi.org/10.12659/AJCR.923722
Rights and permissions
About this article
Cite this article
Alirocumab/atorvastatin. Reactions Weekly 1836, 40 (2021). https://doi.org/10.1007/s40278-021-87859-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-87859-0